Real-time enrollment status for this high grade serous adenocarcinoma of ovary clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 5:00 AM UTC
| NCT Number | NCT06084416 |
| Recruiting Status | Recruiting |
| Condition | High Grade Serous Adenocarcinoma of Ovary |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Volastra Therapeutics, Inc. |
| Last Updated on CT.gov | October 13, 2026 (Yesterday) |
As of October 14, 2026: Clinical trial NCT06084416 is currently recruiting participants. This phase1 study for high grade serous adenocarcinoma of ovary is actively seeking new participants at 11 locations across the United States. The study is sponsored by Volastra Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06084416 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06084416 was last updated Yesterday (October 13, 2026). HelloStudys verifies this status automatically.